Cortisol Inactivation by 11β-Hydroxysteroid dehydrogenase-2 May Enhance Endometrial Angiogenesis via Reduced Thrombospondin-1 in Heavy Menstruation
article
OA: closed
CC0
⤵ 15 in-corpus citations
AI-generated summary
Women with heavy menstrual bleeding show higher endometrial 11β-HSD2 and lower TSP-1, suggesting cortisol inactivation enhances angiogenesis by reducing TSP-1.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
CONTEXT: Heavy menstrual bleeding (HMB; menorrhagia) impairs quality of life for women and requires medication or surgery. Because glucocorticoids inhibit angiogenesis in other organs, we hypothesized that endometrium of women with HMB is subject to decreased local glucocorticoid exposure and enhanced angiogenesis, thereby increasing menstrual bleeding. DESIGN: Endometrium was collected from 29 women with menstrual complaints. Menstrual blood loss was measured by alkaline-hematin assay (n = 12, > 80 ml (HMB); n = 17, < 80 ml). Quantitative RT-PCR for thrombospondin-1 (TSP-1) and glucocorticoid-metabolizing enzymes, 11beta-hydroxysteroid dehydrogenases-1 and -2 (11betaHSD1,2) was performed. Glucocorticoid effects on endometrial stromal cells and uterine endothelial cells (UECs) were determined. RNA interference studies in UECs examined the effect of TSP-1 ablation on cortisol action. RESULTS: Secretory phase endometrium mRNA levels for the cortisol inactivating enzyme 11betaHSD2 were higher [3.78 +/- 1.29 vs. 1.40 +/- 0.6 (arbitrary units), P < 0.05], whereas TSP-1 mRNA was lower [0.40 +/- 0.13 vs. 1.66 +/- 1.02 (arbitrary units), P < 0.05] in women with HMB. In cultured endometrial stromal cells and UECs, cortisol increased TSP-1 expression. Both cortisol and TSP-1 inhibited new vessel formation in endometrial explants embedded in Matrigel. In UECs cortisol inhibition of tube-like structure formation was blocked by small interfering RNA (siRNA) against TSP-1 (25 +/- 2.5% cortisol inhibition with scrambled siRNA vs. 0% cortisol inhibition with TSP-1 siRNA inactivation, P<0.01). CONCLUSIONS: Enhanced inactivation of cortisol by 11betaHSD2 in endometrium from women with HMB may explain reduced TSP-1 levels and hence endothelial cell dysfunction and abnormal angiogenesis. Inhibition of 11betaHSD2 may be a rational novel therapy for heavy menstrual bleeding.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (47)
- Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation via openalex
- Dating the Endometrial Biopsy via openalex
- Endocrine Regulation of Menstruation via openalex
- Endometrial sex steroid receptor expression in women with menorrhagia via openalex
- Increased uterine prostaglandin E receptors in menorrhagic women via openalex
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding via openalex
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia via openalex
- Regulation of angiogenesis in the endometrium via openalex
- The effect of a prostaglandin synthetase inhibitor, indomethacin, on excessive uterine bleeding. via openalex
- Transforming Growth Factor-β1 Attenuates Expression of Both the Progesterone Receptor and Dickkopf in Differentiated Human Endometrial Stromal Cells via openalex
- Vascular smooth muscle cell proliferation in arterioles of the human endometrium via openalex
- doi:10.1016/s0140-6736(82)90183-0 via openalex
- doi:10.1016/j.exer.2004.07.005 via openalex
- W2017784478 via openalex
- doi:10.1136/bmj.38376.505382.ae via openalex
- doi:10.1067/mva.2001.112318 via openalex
- doi:10.1002/jcb.10524 via openalex
- doi:10.1006/excr.1997.3681 via openalex
- doi:10.1196/annals.1335.003 via openalex
- doi:10.1016/j.jss.2004.05.015 via openalex
- W2918154310 via openalex
- W6635336162 via openalex
- W6675069216 via openalex
- W6715698719 via openalex
- W6759754431 via openalex
- doi:10.1210/jc.2002-021174 via openalex
- doi:10.1016/j.mce.2005.12.010 via openalex
- doi:10.1016/j.fertnstert.2004.02.100 via openalex
- doi:10.1007/s10456-005-9006-9 via openalex
- doi:10.1210/jc.2003-032225 via openalex
- doi:10.1073/pnas.0500641102 via openalex
- doi:10.1016/j.ajog.2003.11.016 via openalex
- doi:10.1210/jc.2004-1814 via openalex
- doi:10.1002/jemt.10279 via openalex
- doi:10.1210/jcem.86.10.8101 via openalex
- doi:10.1016/s0039-6060(99)70156-x via openalex
- doi:10.1677/jme.0.0330175 via openalex
- doi:10.4324/9780367801892 via openalex
- doi:10.1159/000092856 via openalex
- doi:10.1016/s0140-6736(88)90742-8 via openalex
- doi:10.1172/jci118429 via openalex
- W1442973484 via openalex
- doi:10.1055/s-0037-1612958 via openalex
- doi:10.1126/science.2845584 via openalex
- doi:10.1111/j.2042-7158.1994.tb03767.x via openalex
Cited by (15)
- Luteal phase oral dexamethasone administration alters the endometrial steroid milieu 2025
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Uterine bleeding: how understanding endometrial physiology underpins menstrual health 2022
- Low dose dexamethasone as treatment for women with heavy menstrual bleeding: A response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM) 2021
- Transforming Growth Factor (TGF) β and Endometrial Vascular Maturation 2021
- The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles 2021
- Physiology of the Endometrium and Regulation of Menstruation 2020
- The Role of the Glucocorticoid Receptor Signalling Pathway within the Human Endometrium 2019
- Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation 2018
- Reduced Transforming Growth Factor-β Activity in the Endometrium of Women With Heavy Menstrual Bleeding 2017
- Differential Gene Expression in Menstrual Endometrium From Women With Self-Reported Heavy Menstrual Bleeding 2016
- Cortisol regulates the paracrine action of macrophages by inducing vasoactive gene expression in endometrial cells 2015
- Menstrual physiology: implications for endometrial pathology and beyond 2015
- Steroid regulation of menstrual bleeding and endometrial repair 2012
- Sex Steroid Hormones and Reproductive Disorders 2011
Source provenance
- openalex
- last seen: 2026-05-10T11:13:04.200457+00:00
License: CC0
· commercial use OK